Insulin Glargine Plus OHAs Versus Biphasic Insulin in Type 2 Diabetes-A Cost Comparison

被引：0
|
作者：
Owens, David
Evans, Marc
Carroll, Dawn
Keech, Martin
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A141 / A141
页数：1
相关论文
共 50 条
  • [31] Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
    Rosenstock, Julio
    Eliaschewitz, Freddy G.
    Heilmann, Cory R.
    Muchmore, Douglas B.
    Hayes, Risa P.
    Belin, Ruth M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S63 - S73
  • [32] Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus exenatide or insulin glargine plus liraglutide
    Di Genio, A.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    Dalal, M. R.
    [J]. DIABETOLOGIA, 2012, 55 : S328 - S328
  • [33] Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
    Rosenstock, Julio
    Lorber, Daniel L.
    Gnudi, Luigi
    Howard, Campbell P.
    Bilheimer, David W.
    Chang, P-C
    Petrucci, Richard E.
    Boss, Anders H.
    Richardson, Peter C.
    [J]. LANCET, 2010, 375 (9733): : 2244 - 2253
  • [34] An analysis of the cost-effectiveness of switching from biphasic human insulin 30, insulin glargine, or neutral protamine Hagedorn to biphasic insulin aspart 30 in people with type 2 diabetes
    Gupta, Vishal
    Baabbad, Ranya
    Hammerby, Eva
    Nikolajsen, Annie
    Shafie, Asrul Akmal
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (04) : 263 - 272
  • [35] Comparison of Insulin Glargine with Insulin Degludec in Type 1 Diabetes Patients
    Kuroda, Akio
    Tsuruo, Miho
    Takeshi, Kondo
    Aki, Nanako
    Oguro, Yukari
    Endo, Itsuro
    Aihara, Ken-ichi
    Tamaki, Motoyuki
    Matsumoto, Toshio
    Matsuhisa, Munehide
    [J]. DIABETES, 2014, 63 : A232 - A232
  • [36] Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
    Pan, CY
    Bianchi-Biscay, M
    Chung, KD
    Kim, KW
    [J]. DIABETES, 2004, 53 : A488 - A488
  • [37] Latin American clinical trial project on insulin glargine versus NPH insulin plus glimepiride in Type 2 diabetes.
    Eliaschewitz, FG
    Calvo, C
    Valbuena, H
    Ruiz, M
    Aschner, P
    Villena, J
    Ramirez, LA
    Jimenez, J
    Macêdo, M
    [J]. DIABETOLOGIA, 2003, 46 : A272 - A272
  • [38] Comparison of equivalent daily doses of biphasic insulin aspart and insulin glargine during isoglycaemic clamp studies in persons with Type 2 diabetes
    Luzio, SD
    Peter, R
    Dunseath, GJ
    Pauvaday, V
    Owens, DR
    [J]. DIABETOLOGIA, 2004, 47 : A268 - A269
  • [39] Glycaemic control and hypoglycaemia in Asian Type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride
    Pan, CY
    Bianchi-Biscay, M
    Chung, KD
    Kim, KW
    [J]. DIABETOLOGIA, 2004, 47 : A271 - A271
  • [40] COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
    Saiyarsarai, P.
    Khosroshahi, Ghazizadeh A.
    Khedmati, J.
    Ghaffari, S.
    Soleymani, F.
    Seyyedifar, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S576 - S576
12345